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Abstract
Background
The prescription rate of antibiotics is high for febrile children visiting the emergency department
(ED), contributing to antimicrobial resistance. Large studies at European EDs covering diver-
sity in antibiotic and broad-spectrum prescriptions in all febrile children are lacking. A better
understanding of variability in antibiotic prescriptions in EDs and its relation with viral or
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bacterial disease is essential for the development and implementation of interventions to opti-
mise antibiotic use. As part of the PERFORM (Personalised Risk assessment in Febrile illness
to Optimise Real-life Management across the European Union) project, the MOFICHE (Man-
agement and Outcome of Fever in Children in Europe) study aims to investigate variation and
appropriateness of antibiotic prescription in febrile children visiting EDs in Europe.
Methods and findings
Between January 2017 and April 2018, data were prospectively collected on febrile children
aged 0–18 years presenting to 12 EDs in 8 European countries (Austria, Germany, Greece,
Latvia, the Netherlands [n = 3], Spain, Slovenia, United Kingdom [n = 3]). These EDs were
based in university hospitals (n = 9) or large teaching hospitals (n = 3). Main outcomes were
(1) antibiotic prescription rate; (2) the proportion of antibiotics that were broad-spectrum
antibiotics; (3) the proportion of antibiotics of appropriate indication (presumed bacterial),
inappropriate indication (presumed viral), or inconclusive indication (unknown bacterial/viral
or other); (4) the proportion of oral antibiotics of inappropriate duration; and (5) the propor-
tion of antibiotics that were guideline-concordant in uncomplicated urinary and upper and
lower respiratory tract infections (RTIs). We determined variation of antibiotic prescription
and broad-spectrum prescription by calculating standardised prescription rates using multi-
level logistic regression and adjusted for general characteristics (e.g., age, sex, comorbidity,
referral), disease severity (e.g., triage level, fever duration, presence of alarming signs), use
and result of diagnostics, and focus and cause of infection. In this analysis of 35,650 children
(median age 2.8 years, 55% male), overall antibiotic prescription rate was 31.9% (range
across EDs: 22.4%–41.6%), and among those prescriptions, the broad-spectrum antibiotic
prescription rate was 52.1% (range across EDs: 33.0%–90.3%). After standardisation, dif-
ferences in antibiotic prescriptions ranged from 0.8 to 1.4, and the ratio between broad-
spectrum and narrow-spectrum prescriptions ranged from 0.7 to 1.8 across EDs. Standard-
ised antibiotic prescription rates varied for presumed bacterial infections (0.9 to 1.1), pre-
sumed viral infections (0.1 to 3.3), and infections of unknown cause (0.1 to 1.8). In all febrile
children, antibiotic prescriptions were appropriate in 65.0% of prescriptions, inappropriate in
12.5% (range across EDs: 0.6%–29.3%), and inconclusive in 22.5% (range across EDs:
0.4%–60.8%). Prescriptions were of inappropriate duration in 20% of oral prescriptions
(range across EDs: 4.4%–59.0%). Oral prescriptions were not concordant with the local
guideline in 22.3% (range across EDs: 11.8%–47.3%) of prescriptions in uncomplicated
RTIs and in 45.1% (range across EDs: 11.1%–100%) of prescriptions in uncomplicated uri-
nary tract infections. A limitation of our study is that the included EDs are not representative
of all febrile children attending EDs in that country.
Conclusions
In this study, we observed wide variation between European EDs in prescriptions of antibiot-
ics and broad-spectrum antibiotics in febrile children. Overall, one-third of prescriptions
were inappropriate or inconclusive, with marked variation between EDs. Until better diag-
nostics are available to accurately differentiate between bacterial and viral aetiologies,
implementation of antimicrobial stewardship guidelines across Europe is necessary to limit
antimicrobial resistance.
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Author summary
Why was this study done?
• Respiratory infections, which are mainly caused by viruses, account for the majority of
antibiotic use in children. In children with respiratory infections, antibiotic prescription
rates vary across emergency departments (EDs) in Europe.
• In order to optimise antibiotic prescriptions, it is important to better understand vari-
ability and appropriateness in antibiotic prescriptions.
What did the researchers do and find?
• In this prospective observational study, we included routine information of 35,650 chil-
dren (median age 2.8 years) with fever attending 12 different EDs in Europe and calcu-
lated the proportion of antibiotic prescriptions and broad-spectrum antibiotic
prescriptions. We adjusted for differences in population including age, comorbidity,
disease severity, and focus and cause of infection.
• Across EDs, antibiotic prescription rates ranged between 22.4% and 41.6%, and of these
prescriptions, broad-spectrum antibiotic rates ranged between 33.0% and 90.3%. Stan-
dardised antibiotic prescription rates ranged between 0.77 and 1.35, and standardised
rates of broad-spectrum antibiotics ranged between 0.65 and 1.75.
• Prescriptions that were inappropriately indicated ranged from 0.6% to 29.3%, and
inconclusive prescriptions ranged from 0.5% to 61.7%. The proportion of oral prescrip-
tions with inappropriate duration ranged from 4.4% to 59.0%.
What do these findings mean?
• In this study we found variation of prescription of antibiotics and broad-spectrum anti-
biotics between EDs in children with fever, even when correcting for age, comorbidity,
disease severity, diagnostics, and focus and cause of infection.
• Variation was especially large in prescriptions for viral infections and infections of
unknown cause.
• In this cohort of febrile children, one-third of prescriptions were of inappropriate or
inconclusive indication, with variation between EDs. In addition, guideline concor-
dance for respiratory and urinary infections varied widely across EDs.
• Generalisation of these results to all EDs in Europe should be undertaken with caution.
• Implementation of guidelines is needed to improve appropriate prescription of antibiot-
ics, whilst new biomarkers will further improve antibiotic prescription.
Introduction
Fever is one of the most common reasons for children to visit the emergency department
(ED), and most visits are accounted for by self-limiting infections [1,2]. The proportion of
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children with a serious bacterial infection that needs treatment with antibiotics ranges from
7% to 13%, while antibiotic prescription rates in febrile children at EDs are between 19% and
64% [3–5]. Inappropriate antibiotic use, including the unnecessary use of broad-spectrum
antibiotics, remains high in children, promoting the emergence of antimicrobial resistance [6–
9]. Inappropriate antibiotic prescriptions were described in around 30% of outpatient pre-
scriptions. However, these outpatient settings mainly involve primary care, and limited studies
are available on specific emergency care [6,10].
Large variability exists between countries in antibiotic prescriptions in inpatient and outpa-
tient settings, according to several large studies [6,8,11–14]. In general, these large studies did
not adjust for differences in populations. In children, previous studies have demonstrated sub-
stantial variation of antibiotic use in general outpatient settings in the United States and
Europe, indicating possible overuse of antibiotics [5,6,10,15].
A literature review on antibiotic prescription rates and their determinants in febrile chil-
dren in emergency care found large heterogeneity of studied populations, which limited the
ability to draw conclusions [16]. One recent European study, focusing solely on EDs, showed
significant differences in antibiotic prescription rates in otherwise healthy children with respi-
ratory tract infections (RTIs) [5]. Large studies at EDs across Europe are lacking that cover
antibiotic and broad-spectrum prescriptions in all febrile children, including patients with
comorbidity, patients with detailed clinical information, and patients in different diagnostic
groups. Additionally, previous studies have addressed appropriate prescribing based on diag-
nosis coded with the International Classification of Diseases [6,10,17]. This classification, how-
ever, may not accurately take into account bacterial versus viral aetiology. Antibiotic
prescription rates for viral and bacterial disease using a structured classification have not yet
been investigated at EDs.
A better understanding of variability in antibiotic prescriptions in EDs and its relation with
bacterial or viral disease, taking into account differences in case mix, is essential for the devel-
opment and implementation of interventions to optimise antibiotic use. In addition, knowl-
edge regarding variation of prescribing in infections where antibiotic prescription is
inappropriate, such as prescriptions in viral disease, prescriptions of inappropriate duration,
or prescriptions that are not concordant with guidelines, could target and improve implemen-
tation of antimicrobial stewardship guidelines at the ED level.
In this study, we aim to investigate the variation and appropriateness of rates and types of
antibiotic prescription in febrile children attending 12 different EDs in Europe.
This is a main analysis of the MOFICHE (Management and Outcome of Fever in Children
in Europe) study, which is embedded in the PERFORM (Personalised Risk assessment in
Febrile illness to Optimise Real-life Management across the European Union) project (https://
www.perform2020.org) [18]. MOFICHE is an observational multicentre study that studies the
management and outcome of febrile children in Europe using routine data. The overall aim of
PERFORM is to improve management of febrile children and to improve diagnosis through
development of new diagnostic tests to discriminate viral and bacterial infections in children.
Methods
Study design
MOFICHE is a prospective observational study using data that are collected as part of routine
care. This study is reported as per the Strengthening the Reporting of Observational Studies in
Epidemiology (STROBE) guideline (S1 Text), and data were analysed using an a priori statisti-
cal analysis plan (S2 Text). The study was approved by the ethics committees in the participat-
ing hospitals, and the need for informed consent was waived (S3 Text).
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Study population and setting
Children aged 0–18 years presenting with fever (temperature� 38.0˚C) or a history of fever
(fever within 72 hours before ED visit) were included. Twelve EDs from 8 European countries
participated in this study: Austria, Germany, Greece, Latvia, the Netherlands (n = 3), Spain,
Slovenia, and the United Kingdom (n = 3). The EDs were included because they all partici-
pated in the PERFORM project. Characteristics of these EDs are described in S4 Text and in a
previous publication [19]. In short, the participating hospitals were either university hospitals
(n = 9) or large teaching hospitals (n = 3), and 11 EDs had paediatric intensive care facilities.
Nine EDs were paediatric focused, and 3 EDs served both children and adults. Care for febrile
children was supervised by general paediatricians (7 EDs), by paediatric emergency physicians
(2 EDs), or by a general paediatrician or a (paediatric) emergency physician (3 EDs). All data
were available in electronic healthcare records in 5 EDs, 1 ED used paper records, and 6 EDs
used a combination of paper and electronic healthcare records.
Data were collected from January 2017 until April 2018, and for at least 1 year at each site
to include all seasons. The period of data collection per month ranged from 1 week per month
to the whole month in the participating hospitals (S4 Text).
Sample size
We expected to include 40,000 children with at most 5% missing data. Pilot data showed an
overall antibiotic prescription rate of 30%. Applying 10 events per variable, this study is large
enough to analyse over 1,000 determinants for the outcome antibiotic prescription [20]. We
performed a post hoc sample size estimation for a desired width of the 95% confidence interval
(CI) of standardised antibiotic prescription rate per ED. The expected width of the CI of the
standardised prescription rate was below 0.5 for the smallest ED.
Data collection
Data were collected as part of routine ED care. The local research team entered data from
patient records in an electronic case record form (eCRF) [21]. Collected data included age, sex,
season, referral, comorbidity (chronic condition expected to last at least 1 year) [22], triage
urgency, fever duration, fever measured at ED, presence of “red traffic light” symptoms for
identifying risk of serious illness (alarming signs) (from the National Institute for Health and
Care Excellence [NICE] guideline on fever [23]: decreased consciousness, ill appearance, work
of breathing, meningeal signs, focal neurology, non-blanching rash, dehydration, status epilep-
ticus), previous antibiotic use, vital signs (heart rate, respiratory rate, oxygen saturation, tem-
perature, capillary refill time), laboratory results (white blood cell count, C-reactive protein
[CRP], urinalysis), imaging (chest X-ray and other imaging), microbiological investigations
(cultures and respiratory viral tests), and disposition (intensive care unit admission, general
ward admission or discharge). We collected data on antibiotics prescribed in the ED or started
on the first day of hospital admission (type, route of administration, and duration). The focus
of infection was categorised as upper respiratory tract (otitis media, tonsillitis/pharyngitis,
other), lower respiratory tract, gastrointestinal tract, urinary tract, skin, musculoskeletal, sep-
sis, central nervous system, flu-like illness, childhood exanthem, inflammatory syndrome,
undifferentiated fever, or other.
To date, no reference standard exists to classify the cause of infection in routine ED practice
[24]. The PERFORM consortium adapted the consensus-based flowchart from Herberg and
colleagues [25,26], combining all available clinical data, investigation results such as CRP, cul-
tures, and imaging. This flowchart was used to define the presumed cause of infection for each
patient visit: definite bacterial, probable bacterial, bacterial syndrome, unknown bacterial/
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viral, viral syndrome, probable viral, definite viral, trivial, inflammatory syndrome, and other
(Fig 1). The diagnosis definite bacterial infection was assigned only when a sterile site culture
identified pathogenic bacteria. The diagnosis ‘probable bacterial infection’ was assigned when
a bacterial syndrome was suspected but no bacteria were identified and CRP was above 60 mg/
l. Patients with clinical bacterial symptoms and CRP� 60 mg/l or no CRP were classified as
‘bacterial syndrome’. Children with suspected viral infections were classified as ‘viral syn-
drome’ (no CRP or CRP > 60 mg/l) or ‘definite viral’ (CRP� 60 mg/l) when a virus was iden-
tified that matched the clinical symptoms. Children with a viral syndrome and CRP� 60 mg/l,
but no identified virus, were classified as ‘probable viral’. Children who did not fit these defini-
tions were classified as unknown bacterial/viral. Children with mixed infections (bacterial and
viral co-infection) were classified as bacterial. Children with trivial infections, inflammatory
syndrome, or other infections were classified as ‘other’.
Fig 1. Categorisation of presumed cause of infection. CRP, C-reactive protein; LRTI, lower respiratory tract infection; URTI, upper respiratory tract infection.
�Patients could have identified viral co-infection.
https://doi.org/10.1371/journal.pmed.1003208.g001
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We aimed to improve data quality and standardised data collection by using a training
module for the local clinical and research teams to optimise clinical assessment and data col-
lection for febrile children. This training module included clarification of the individual alarm-
ing signs and classification examples of common diagnoses. Furthermore, entry guidelines for
the eCRF were available, monthly teleconferences and biannual meetings were organised, and
quarterly reports of data quality for each ED were discussed. These consortium teleconferences
also included discussion of difficult cases.
Antibiotic classification
Antibiotics were categorised using the Anatomical Therapeutic Chemical classification including
beta-lactamase sensitive penicillins (J01CE); beta-lactamase resistant penicillins (J01CF); penicil-
lins with extended spectrum (J01CA); combinations of penicillins including beta-lactamase inhib-
itors (J01CR); macrolides (J01FA); first-generation, second-generation, and third-generation
cephalosporins (J01DB, J01DC, J01DD); trimethoprim and sulphonamides (J01EA01, J01EE01);
aminoglycosides (J01GB); quinolones (J01MA); glycopeptides (J01XA); and other antibiotics.
In addition, we compared the prescription of narrow-spectrum and broad-spectrum antibi-
otics. We explored the definitions reported in previous studies on antibiotic classification and
used an expert opinion panel including paediatric infectious disease specialists and general
paediatricians (PERFORM partners), to establish the final classification into broad-spectrum
and narrow-spectrum for all systemic antibiotics [5,6,11,15,27,28]. Narrow-spectrum antibiot-
ics comprised penicillins (e.g., amoxicillin) and first-generation cephalosporins. Broad-spec-
trum antibiotics included penicillins with beta-lactamase inhibitor combinations (e.g.,
amoxicillin/clavulanic acid), macrolides, aminoglycosides, glycopeptides, and second-genera-
tion and third-generation cephalosporins. Prescriptions of both broad-spectrum and narrow-
spectrum antibiotics in the same patient were considered broad-spectrum. Topical antibiotics
were not included. Details of this classification are presented in S5 Text.
Outcomes
We assessed various aspects of antibiotic prescription: (1) antibiotic prescription rate; (2) the
proportion of antibiotics that were broad-spectrum versus narrow-spectrum; (3) the proportion
of antibiotics of ‘likely appropriate’ indication (presumed bacterial), ‘likely inappropriate’ indi-
cation (presumed viral), or ‘inconclusive’ indication (unknown bacterial/viral); (4) the propor-
tion of oral antibiotics of inappropriate duration; and (5) the proportion of oral antibiotics that
matched the antibiotic type in the local guideline (‘guideline-concordant’) in uncomplicated
urinary and upper and lower RTIs. Antibiotic prescriptions were classified as likely appropriate
in presumed bacterial infections (definite bacterial, probable bacterial, bacterial syndrome),
likely inappropriate in presumed viral infections (definite viral, probable viral, viral syndrome),
and inconclusive in unknown bacterial/viral infections or other infections. Inappropriate dura-
tion was defined as>10 days for treatment of tonsillitis with beta-lactamase sensitive penicillins
(J01CE) and>7 days for all other prescriptions according to recommendations by international
guidelines [29–31]. In addition, guideline-concordant prescription in patients with uncompli-
cated RTIs and uncomplicated urinary tract infections was defined according to the local guide-
line (S6 Text). Uncomplicated infections were defined as infections in previously healthy
children who did not receive therapeutic antibiotic treatment before the ED visit.
Data analysis
Missing values were assumed to be missing at random, and therefore we used multiple imputa-
tion by chained equations with the MICE package in R for the regression analysis. We
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excluded patients with missing data on antibiotic prescription, presumed cause of infection,
and focus of infection [32]. Only the first visit was included for patients who visited the ED
again within 5 days.
First, we performed a descriptive analysis of the frequency of antibiotic prescription and
broad-spectrum and narrow-spectrum prescription, including ranges across EDs. For all out-
comes, we calculated the overall proportion and proportion per ED. Second, we used multi-
level logistic regression with a random intercept for each ED to study variation between EDs
in antibiotic prescription, broad-spectrum prescription versus narrow-spectrum prescription,
and intravenous/intramuscular versus oral prescriptions [33]. In an adjusted model we cor-
rected for patient-level factors and for hospital-level factors influencing antibiotic prescribing.
Patient-level factors were selected a priori according to the literature [3,4,23,34,35] and
included general characteristics (age, sex, season, comorbidity, referral [referred versus self-
referred]), markers for disease severity such as triage urgency (high urgency [immediate, very
urgent, urgent] versus low urgency [standard, non-urgent]), fever duration in days, fever mea-
sured at ED visit (�38˚C), and presence of NICE guideline “red traffic light” alarming signs
(0, 1,�2). We investigated diagnostics, including CRP (not performed or <20, 20–60, or >60
mg/l) [25,36], chest X-ray (not performed, normal, abnormal), and urinalysis (not performed,
normal, abnormal [positive for leukocyte esterase and/or nitrite]). Furthermore, we included
focus of infection (upper respiratory tract, lower respiratory tract, gastrointestinal, urinary
tract, undifferentiated fever, skin/musculoskeletal, sepsis/central nervous system, flu-like ill-
ness/childhood exanthem, inflammatory/other) and diagnostic groups according to cause as
classified by the flowchart in Fig 1: presumed bacterial (definite bacterial, probable bacterial,
bacterial syndrome), unknown bacterial/viral, presumed viral (definite viral, probable viral,
viral syndrome), and other.
For the hospital-level factors, we explored variables that varied between hospitals and were
related to antibiotic prescribing [19,37–40]: total number of ED visits, supervision, availability
of point-of-care tests (streptococcal antigen test and CRP), and primary care during out-of-
office hours. We included hospital-level factors if they improved the model using univariate
analysis. Linearity of continuous variables was tested using restricted cubic splines. Specifica-
tions of the adjusted model are presented in Table 1 and in S7 Text.
Table 1. Variables in the adjusted model.
Category Variables
Patient-level factors
General
characteristics
Age�, sex, season, comorbidity, referral
Disease severity Triage urgency, fever duration, fever measured at ED, presence of NICE alarming signs,
previous antibiotic use˚
Diagnostics C-reactive protein, chest X-ray, urinalysis
Infection Focus of infection, cause of infection
Hospital-level
factors±
Total number of ED visits, supervision, availability of point-of-care tests (streptococcal
antigen test and C-reactive protein), primary care during out-of-office hours±
�Age was modelled using restricted cubic splines (3 knots).
˚Previous antibiotic use was added in the models with outcome broad-spectrum versus narrow-spectrum
prescription.
±None of the hospital-level factors were significant, and therefore they were not included in the final model.
ED, emergency department; NICE, National Institute for Health and Care Excellence.
https://doi.org/10.1371/journal.pmed.1003208.t001
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Variation in antibiotic prescription rates between EDs was determined by 2 measures: stan-
dardised prescription rates and median odds ratios (MORs). We calculated standardised anti-
biotic prescription rates using indirect standardisation, where the expected number of
antibiotic prescriptions was standardised to the average ED. Standardised antibiotic prescrip-
tion ratios are the ratio between observed antibiotic prescriptions in an ED and the expected
antibiotic prescriptions in an ED. The expected number of antibiotic prescriptions was esti-
mated through the adjusted model, by summing the predicted probabilities from the adjusted
model of antibiotic prescription for each of the patients. Standardised rates > 1 indicate higher
prescription rates than expected, and standardized rates < 1 indicate lower prescription rates
than expected. We visualised standardised rates in a heat map.
The MOR is a measure of variation between high- and low-prescribing clusters of EDs. The
MOR reflects the difference in probability of receiving antibiotics comparing similar patients
attending an ED with high antibiotic prescribing and an ED with low antibiotic prescribing. If
the MOR is equal to 1.00, there is no variation between clusters, and if the MOR is high, this
indicates important between-cluster variation [41,42].
Stratified analyses were performed in patients with and without comorbidities. Also, since
antimicrobial resistance patterns vary greatly between European countries, standardised rates
of broad-spectrum versus narrow-spectrum antibiotic prescription were compared with anti-
microbial resistance data of invasive isolates on a national level and at the hospital level [11,43]
(S8 Text). Correlations were calculated using the 2-tailed Spearman’s rank coefficient (ρ). A p-
value below 0.05 was considered significant.
Appropriateness of antibiotic prescriptions
We calculated standardised rates for antibiotic prescription and broad-spectrum prescription
in groups of presumed viral infections, presumed bacterial infections, and unknown bacterial/
viral infections. Next, we assessed the proportion of all antibiotic prescriptions that were likely
appropriate, likely inappropriate, and inconclusive. For all oral prescriptions, we calculated the
proportion of prescriptions that were both inappropriate in indication (likely inappropriate)
and of inappropriate duration, and the proportion of prescriptions that were either inappro-
priate in indication or inappropriate in duration. In uncomplicated RTIs and urinary tract
infections, we calculated the proportion of all oral prescriptions that were inappropriate for all
the 3 measures (indication, duration, and guideline concordance), and the proportion of pre-
scriptions that were inappropriate in any of the 3 measures. R version 3.4 was used for the
analysis and visualisation of the data.
Results
Study population
Of the total population of 38,480 patients, we excluded 738 patients based on missing data of
antibiotics or diagnosis, and the repeated visit of 2,092 patients to the same ED. Compared to
patients with complete outcome data, patients with missing data were similar in age, sex,
comorbidity, and admission rate (S9 Text). In addition, there were no differences in complete-
ness of outcomes and diagnosis between discharged and admitted patients.
For the analysis, we included 35,650 febrile children (median age 2.8 years [IQR 1.3–5.6],
54.6% male). The different EDs varied substantially in patients who were referred (range:
4.9%–99.2%), were ill appearing (range: 0.8%–47.4%), or had any comorbidity (range: 5.1%–
65.3%) (Table 2). The most common infections were upper respiratory tract (n = 18,783,
52.7%), lower respiratory tract (n = 5,167, 14.5%), gastrointestinal tract (n = 3,694, 10.4%), and
undifferentiated fever (n = 2,784, 7.8%). The incidence of sepsis and central nervous system
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infections was low (n = 270, 0.8%). The majority of the children had a presumed viral infection
(n = 20,383, 57.2%); presumed bacterial infections occurred in 22.1% of the patients (definite
bacterial, 4.1%; probable bacterial/bacterial syndrome, 18.1%), and unknown bacterial/viral
infections in 14.6% (n = 5,200) (Table 3).
Overall antibiotic prescriptions
The overall antibiotic prescription rate was 31.9% (n = 11,371), of which 67.2% (7,636/11,731)
were oral administrations and 31.3% (3,564/11,371) were administered intravenously or intra-
muscularly (153 children received a single dose at the ED). One-third of patients were treated
Table 2. Patient characteristics of the study population (n = 35,650).
Characteristic n (%) or median (IQR) Range across EDs (%) Missing, n (%)
Age in years 2.77 (1.32–5.59)
Male 19,476 (54.6) 51.5–59.1 1 (0.0)
Comorbidity 5,889 (16.5) 5.1–65.3 326 (0.9)
Season 1,111 (3.1)
Winter 12,665 (35.5) 26.8–53.2
Spring 9,054 (25.4) 18.2–31.2
Summer 5,767 (16.2) 9.5–23.5
Autumn 8,164 (22.9) 6.9–31.4
Triage urgency 1,059 (2.9)
High: immediate, very urgent, urgent 12,251 (34.4) 8.3–88.5
Low: standard, non-urgent 22,340 (62.7) 10.1–91.6
Referred 15,104 (42.4) 4.9–99.2 1,110 (3.1)
Fever duration in days 1.5 (0–3) 2,449 (6.9)
NICE “red traffic light” alarming signs
Ill appearance 5,567 (15.6) 0.8–47.4 1,525 (4.3)
Work of breathing 2,987 (8.4) 3.2–25.7 4,482 (12.6)
Dehydration 1,763 (4.9) 0.4–15.2 6,323 (17.7)
Rash: petechiae/non-blanching 1,039 (2.9) 1.4–5.8 3,963 (11.1)
Decreased consciousness 188 (0.5) 0.1–3.8 334 (0.9)
Meningeal signs 132 (0.4) 0.1–1.7 1,807 (5.1)
Focal neurology 121 (0.3) 0.0–2.6 2,224 (6.2)
Status epilepticus 60 (0.2) 0.0–1.9 1,099 (3.1)
C-reactive protein (CRP)
No CRP performed 19,578 (54.9) 7.9–93.2
<20 mg/l 8,729 (24.5) 3.2–58.4
20–60 mg/l 4,191 (11.8) 1.9–24.9
>60 mg/l 3,152 (8.8) 1.6–30.2
Chest X-ray
No 30,662 (86.0) 78.6–93.8
Normal 1,931 (5.4) 0.9–10.0
Abnormal 3,057 (8.6) 2.9–12.8
Urinalysis
No 26,691 (74.9) 60.8–91.4
Normal 7,210 (20.2) 7.1–29.8
Abnormal 1,749 (4.9) 1.5–9.5
ED, emergency department; IQR, interquartile range; NICE, National Institute for Health and Care Excellence.
https://doi.org/10.1371/journal.pmed.1003208.t002
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with antibiotics for over 7 days (3,534/9,391, 37.6%) (S1 Fig). The types of antibiotics most often
prescribed were penicillins with extended spectrum (3,220/11,371, 28.3%), combinations of peni-
cillins with beta-lactamase inhibitors (2,309/11,371, 20.3%), and beta-lactamase sensitive penicil-
lins (2,001/11,371, 17.6%). Half of the prescribed antibiotics were broad-spectrum agents (5,887/
11,371, 51.7%). The most prescribed broad-spectrum antibiotics were combinations of penicillins
with beta-lactamase inhibitors (2,309/11,371, 20.3%), second-generation cephalosporins (1,154/
11,371, 10.1%), and third-generation cephalosporins (1,097/11,371, 9.6%) (Table 4; Fig 2).
Variation of overall antibiotic prescription and broad-spectrum
prescription
The proportion of febrile children receiving an antibiotic prescription ranged from 22.4% to
41.6% across EDs, and the proportion of those prescriptions that were for broad-spectrum
Table 3. Patient characteristics of the study population: Outcomes, n = 35,650.
Outcome n (%) or median
(IQR)
Range across EDs
(%)
Therapeutic antibiotics use in last 7 days� 3,592 (10.1) 6.6–15.6
Antibiotic treatment duration, days 7 (5–10)
Antibiotics prescribed at ED visit or first day of hospital
admission�
11,371 (31.9) 22.4–41.6
Narrow-spectrum 5,401 (15.2) 3.1–23.2
Broad-spectrum 5,887 (16.5) 9.5–34.7
Antibiotic administration�
Oral 7,636 (21.4) 10.4–34.2
Intravenous/intramuscular 3,564 (9.9) 1.7–21.3
Admission� 9,000 (25.2) 4.5–54.2
ICU admission� 147 (0.4) 0.1–4.3
Focus of infection
Upper respiratory tract 18,783 (52.7) 25.7–70.0
Lower respiratory tract 5,167 (14.5) 8.5–26.4
Gastrointestinal/surgical abdomen 3,694 (10.4) 6.0–19.2
Undifferentiated fever 2,784 (7.8) 1.8–18.8
Flu-like illness/exanthem 1,753 (4.9) 2.0–11.9
Urinary tract 1,231 (3.5) 1.2–5.8
Soft tissue/musculoskeletal 876 (2.5) 0.5–6.8
Sepsis/central nervous system 270 (0.8) 0.0–3.9
Inflammatory 136 (0.4) 0.0–1.3
Other 957 (2.7) 1.2–8.4
Cause of infection
Presumed viral 20,383 (57.2) 37.3–71.4
Definite bacterial 1,451 (4.1) 1.6–10.9
Probable bacterial/bacterial syndrome 6,438 (18.1) 4.7–31.8
Unknown bacterial/viral 5,200 (14.6) 1.6–37.9
Other 2,178 (6.1) 1.1–30.9
�Missing: therapeutic antibiotic use in last 7 days, 681/35,650 (1.9%); antibiotic duration, 1,980/11,371 (17.4%);
broad-spectrum versus narrow-spectrum antibiotics, 83/11,371 (0.7%); antibiotic administration, 171/11,371 (1.5%);
admission and ICU admission, 25/35,650 (0.1%).
ED, emergency department; ICU, intensive care unit; IQR, interquartile range.
https://doi.org/10.1371/journal.pmed.1003208.t003
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Table 4. Frequencies of antibiotic classes and ranges across EDs (n = 11,371).
Antibiotic class n (%) Range across EDs
(%)
Beta-lactamase sensitive penicillins (e.g., benzylpenicillin) 2,001
(17.6)
0.1–32.5
Beta-lactamase resistant penicillins (e.g., flucloxacillin) 167 (1.5) 0.0–8.1
Penicillins with extended spectrum (e.g., amoxicillin) 3,220
(28.3)
2.6–61.6
Combinations of penicillins with beta-lactamase inhibitors (e.g., amoxicillin with
clavulanate)
2,309
(20.3)
1.4–59.0
Macrolides (e.g., azithromycin) 638 (5.6) 2.9–11.0
First-generation cephalosporins 167 (1.4) 0.0–9.8
Second-generation cephalosporins 1,154
(10.1)
0.0–25.6
Third-generation cephalosporins 1,097 (9.6) 1.1–25.1
Trimethoprim and sulphonamides 128 (1.1) 0.0–5.1
Aminoglycosides 205 (1.8) 0.0–15.6
Quinolones 51 (0.4) 0.0–2.8
Glycopeptides 31 (0.3) 0.0–2.7
Other 120 (1.1) 0.0–4.6
Missing 83 (0.7) 0.0–3.6
ED, emergency department.
https://doi.org/10.1371/journal.pmed.1003208.t004
Fig 2. Antibiotic classes of prescribed antibiotics across EDs, n = 35,650. Red shades indicate broad-spectrum classes, blue shades indicate narrow-spectrum classes,
and grey shades indicate unclassified classes and prescriptions of unknown class. EDs are sorted by antibiotic prescription rate. ED, emergency department; NL, the
Netherlands; UK, United Kingdom.
https://doi.org/10.1371/journal.pmed.1003208.g002
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agents ranged from 33.0% to 90.3%. Of the broad-spectrum agents, penicillins with beta-lacta-
mase inhibitors had the largest variation (range 1.4%–59.0%), but other broad-spectrum
agents varied as well (range 17.3%–37.0%). Fig 3 presents the standardised prescription rates
from the adjusted model. None of the hospital-level factors was related with antibiotic pre-
scription (p-value range: 0.14–0.77). After correction for general patient characteristics (age,
sex, season, comorbidity, referral), disease severity (triage urgency, fever duration, fever mea-
sured at ED, alarming signs), diagnostics, focus of infection, and cause of infection, variability
of antibiotic prescriptions remained between EDs in the adjusted model (range of standardised
prescription rates: 0.77–1.35; MOR 2.41). Variation was also observed for intravenous versus
oral administration (range of standardised rates: 0.29–1.31; MOR 2.60) and prescription of
broad-spectrum antibiotics versus narrow-spectrum antibiotics (range of standardised rates:
0.65–1.75; MOR 3.20). Stratified for comorbidity, standardised antibiotic prescription rates
and broad-spectrum rates were comparable in children with and without comorbidity. Higher
standardised rates for broad-spectrum antibiotics were not related to higher antimicrobial
resistance percentages on a national level or on a hospital level (S8 Text). Results of variation
of antibiotic and broad-spectrum prescriptions for RTIs are provided in S10 Text.
Variation of antibiotic and broad-spectrum prescriptions in viral
infections, bacterial infections, and unknown bacterial/viral infections
The antibiotic prescription rate was 6.9% (1,418/20,383) for presumed viral infections (range
across EDs: 0.4%–18.9%), 88.8% (1,289/1,451) for definite bacterial infections (range across
Fig 3. Heat map of standardised prescription rates by ED (95% CI). All adjusted for age, sex, season, comorbidity,
referral, triage urgency, fever measured at ED, fever duration, alarming signs, CRP, chest X-ray, urinalysis, focus of
infection, and cause of infection. EDs are ordered according to standardised antibiotic prescribing rate, from low to
high on the left vertical axis. The coloured boxes represent rank of standardised rate for each ED: Red indicates
rates> 1, blue indicates rates< 1, and rates equal to 1 are white. �Also adjusted for previous antibiotic use. ED,
emergency department; NL, the Netherlands; UK, United Kingdom.
https://doi.org/10.1371/journal.pmed.1003208.g003
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EDs: 83.5%–96.2%), 94.7% (6,097/6,438) for probable bacterial/bacterial syndrome infections
(range across EDs: 81.2%–99.3%), and 45.2% (2,348/5,200) for unknown bacterial/viral infec-
tions (range across EDs: 1.7%–79.3%) (S2 Fig).
Adjusted for general characteristics, disease severity, diagnostics, and focus of infection, we
observed variation for antibiotic prescriptions in presumed viral infections (range of standardised
rates: 0.05–3.29; MOR 4.91) and unknown bacterial/viral infections (range of standardised rates:
0.05–1.78; MOR 4.78) (Fig 4). Antibiotic prescriptions varied less for patients with presumed bac-
terial infections (range of standardised rates: 0.91–1.06; MOR 2.32). The proportion of broad-spec-
trum prescriptions was 74.1% (1,037/1,399) for presumed viral infections (range across EDs:
38.9%–91.4%), 68.5% (880/1,284) for definite bacterial infections (range across EDs: 39.2%–
96.0%), 43.2% for probable bacterial/bacterial syndrome infections (2,628/6,081, range across EDs:
28.5%–86.3%), and 51.6% (1,191/2,306) for unknown bacterial/viral infections (range across EDs:
20.0%–95.7%) (S2 Fig). After adjustment, differences for broad-spectrum versus narrow-spectrum
antibiotics remained for presumed viral infections (range of standardised rates: 0.57–1.54; MOR
2.59), presumed bacterial infections (range of standardised rates: 0.66–1.86; MOR 3.09), and
unknown bacterial/viral infections (range of standardised rates: 0.44–1.64; MOR 3.70) (S3 Fig).
Variation in prescriptions of appropriate indication and appropriate
duration
Of all antibiotic prescriptions, 65.0% (7,386/11,371) were determined to be likely appropriate
(range across EDs: 23.7%–98.9%), 12.5% (1,418/11,371) were likely inappropriate (range
Fig 4. Heat map of standardised antibiotic prescription rates by ED for presumed viral, presumed bacterial, and
unknown bacterial/viral infections (95% CI). All adjusted for age, sex, season, comorbidity, referral, triage urgency,
fever duration, alarming signs, CRP, chest X-ray, urinalysis, and focus of infection. EDs are ordered according to
standardised antibiotic prescribing rate, from low to high on the left vertical axis. The coloured boxes represent rank of
standardised rate for each ED: Red indicates rates> 1, blue indicates rates< 1, and rates equal to 1 are white. ED,
emergency department; NL, the Netherlands; UK, United Kingdom.
https://doi.org/10.1371/journal.pmed.1003208.g004
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across EDs: 0.6%–29.3%), and 22.6% (2,567/11,371) were inconclusive (range across EDs:
0.5%–61.7%).
Oral antibiotic prescriptions with inappropriate duration were found in 20.0% (1,525/
7,636) of prescriptions, and this ranged from 4.4% to 59.0% across EDs (Fig 5). Of all oral anti-
biotic prescriptions, 2.1% (134/7,636) were of both inappropriate indication and inappropriate
duration (range across EDs: 0.0%–8.4%), whereas 30.0% (2,294/7,636) were either of inappro-
priate indication or of inappropriate duration (range across EDs: 11.3%–69.9%).
Variation of appropriate prescriptions in uncomplicated RTIs and urinary
tract infections
In uncomplicated RTIs, oral prescriptions were not guideline-concordant in 22.3% (973/
4,373) of prescriptions (range across EDs: 11.8%–47.3%) (Fig 5). In this group, the proportion
Fig 5. Heat map of inappropriateness of antibiotic prescriptions across EDs. EDs are ordered according to
proportion of inappropriately indicated prescriptions, from low to high on the left vertical axis. The coloured boxes
represent rank of proportion for each ED: Red indicates the highest proportion, and white indicates the lowest
proportion. ED, emergency department; NL, the Netherlands; UK, United Kingdom.
https://doi.org/10.1371/journal.pmed.1003208.g005
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of prescriptions that were inappropriate in all 3 measures (indication, duration, and guideline
concordance) was 0.7% (31/4,373), whilst 42.3% (1,850/4,373) were inappropriate in any of the
3 measures (range across EDs: 15.7%–80.9%). In uncomplicated urinary tract infections, oral
prescriptions were not concordant with the local guideline in 45.1% of prescriptions (152/337)
(range across EDs: 11.1%–100%), and 65.9% (222/337) were inappropriate in any of the 3 mea-
sures (range across EDs: 11.1%–100%).
Discussion
In this large prospective multicentre study, we found diversity in antibiotic prescriptions, and
in particular broad-spectrum antibiotic prescriptions, for febrile children attending different
EDs in Europe. After adjustment for general characteristics, disease severity, diagnostics, and
focus of infection, we observed minor variation in antibiotic prescriptions for bacterial infec-
tions, and larger variability in antibiotic prescriptions for viral infections and unknown bacte-
rial/viral infections. Moreover, one-third of all antibiotic prescriptions were of inappropriate
or inconclusive indication, and 20% of oral prescriptions were of inappropriate duration, with
large variation across EDs. Between EDs, the proportion of oral prescriptions that were not
concordant with the local guideline varied from 12% to 47% in RTIs and from 11% to 100% in
urinary tract infections.
Our study supports previous studies that reported variable antibiotic prescribing for all
febrile children, but found less variation than a previous study in children with RTIs across 28
European EDs (range of standardised rates: 0.5–2.0) [5]. In contrast to this study, our study
corrected for aetiology of infection—bacterial, viral, or unknown—based on a standardised
flowchart. Studies in the US on diversity in outpatient antibiotic prescribing found regional
differences in both antibiotic and broad-spectrum prescribing [6,10,17]. These studies, how-
ever, were not focused on ED visits alone since all ambulatory visits were included.
The Access, Watch, and Reserve (AWaRE) classification has recently been used to classify
global antibiotic prescriptions in 2 studies assessing oral formulations and use of inpatient
antibiotics in children [14,44,45]. These studies confirmed variable patterns of antibiotic pre-
scribing between countries, but did not adjust for differences in population and did not report
data of emergency care visits. Further, the AWaRE classification led to a substantial proportion
of unclassified antibiotics in our study population (12.2%; range across EDs: 1.9%–26.9%) and
absence of the reserve category.
Previous studies in the US have evaluated appropriateness of antibiotic prescribing in chil-
dren defined by ICD codes. Poole et al. [46] found that prescriptions were in general not indi-
cated in 32% of emergency care visits in children. Additionally, overall prescription of first-
line antibiotics (amoxicillin, amoxicillin-clavulanate) ranged from 50% to 78% for RTIs in
children [46–48]. We found a similar rate of guideline-concordant prescriptions in RTIs
(78%), whilst guideline concordance was defined differently for most EDs: amoxicillin and
narrow-spectrum penicillins according to the local guideline. One ED (UK, 3) used amoxicil-
lin-clavulanate as first-line for RTIs. Our study is the first to our knowledge to evaluate appro-
priateness of antibiotic prescribing in febrile children visiting different EDs in Europe, using a
structured flowchart categorising viral, bacterial, and unclassified infections, and taking local
guidelines into account.
Strengths of this European multicentre study include the large sample size, detailed patient
information, recruitment in a diverse range of ED settings in 8 EU countries, and recruitment
over a full year to reflect seasonal variation. Furthermore, a rigorous, standardised structured
assessment of all cases was carried out to establish the presumed cause of infection, using a
consensus-based flowchart taking into account clinical syndrome, CRP, and culture results.
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Previous studies have addressed appropriate prescribing for diagnoses based on ICD codes.
This classification, however, may not accurately take into account bacterial or viral aetiology
[6,10,17,46]. Our large sample size enabled adjustment for hospital- and patient-level factors
influencing antibiotic use in the EDs [19].
This study has some limitations. First, the included EDs are not representative of all febrile
children attending the ED in that country. The EDs participating in this study are university
hospitals or large teaching centres with intensive care unit facilities involved in paediatric
infectious disease research collaborations. Fever and sepsis guidelines were available in all EDs
[19]. Therefore, these EDs represent a high standard of care, and generalisation of our findings
to smaller hospitals or to a regional or national level should be undertaken with caution. How-
ever, we corrected for the most important confounders including comorbidities, multiple
markers of disease severity, and focus and presumed cause of infection. Second, although the
experience of the physician (resident or consultant) and clinician specialty are related with
antibiotic prescription [49,50], we could not adjust for physician background at the patient
level. However, we evaluated the contribution of supervision to antibiotic prescription at the
hospital level. In our study, supervision was not related to antibiotic prescription. Our efforts
to improve data quality by training clinical and research staff might have influenced common
clinical practice. Since this training focused on awareness of alarming signs in the clinical
assessment of the febrile child, it is unlikely that it influenced antibiotic prescription. Further-
more, we only included the first visit of patients who repeatedly visited the ED, since data col-
lection did not include secondary visits in all EDs.
Differences in antibiotic prescribing could be influenced by differences in immunisation
coverage. In our study, countries with lower coverage for pneumococcal vaccinations (<90%)
(Germany, Slovenia) did not have higher antibiotic prescriptions at the ED [19,51].
We found large variation in broad-spectrum prescriptions across the different EDs.
Increased antimicrobial resistance rates could possibly explain higher broad-spectrum pre-
scribing. We compared broad-spectrum rates with national data for antimicrobial resistance
and hospital methicillin resistance rates. Interestingly, EDs based in countries with higher anti-
microbial resistance on a population level (e.g., Greece, Spain) prescribed less broad-spectrum
agents than expected in the ED. These hospitals with higher burden of national antimicrobial
resistance may perceive more problems with antimicrobial resistance and might feel a greater
pressure to reduce antibiotic prescriptions in the ED. It should be noted that antibiotic pre-
scribing in the ED will not be representative of antibiotic prescription patterns of primary care
in the community.
The diversity in antibiotic prescribing across different EDs appears not to be associated
with antimicrobial resistance or immunisation coverage. Although the ideal antibiotic pre-
scription rate is unknown, the diversity in antibiotic prescribing suggests overprescribing. Pre-
scription rates were above the average incidence of serious bacterial infections. We found
variation in antibiotic prescription rates, even when adjusting for general characteristics, dis-
ease severity, diagnostics, and focus and cause of infection.
This suggests room for improvement in reduction of antibiotic prescriptions and especially
broad-spectrum prescriptions at the ED. EDs with higher antibiotic prescription rates did not
necessarily prescribe more broad-spectrum antibiotics. The ED with the highest standardised
broad-spectrum rate (UK, 3) did not have a high proportion of inappropriate prescriptions for
RTIs. In only this ED, amoxicillin-clavulanate (broad-spectrum) was the first-choice agent for
uncomplicated RTIs, which could explain the higher broad-spectrum rate in this ED. Studies
demonstrated that use of narrow-spectrum antibiotics compared to broad-spectrum antibiot-
ics leads to similar clinical outcomes and to fewer adverse events [28,52]. Unnecessary use of
broad-spectrum antibiotics potentially increases resistance rates even further.
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In addition, diversity of antibiotic prescription increased with diagnostic uncertainty. After
adjustment for general characteristics, disease severity, diagnostics, and focus of infection, we
observed minor variation in antibiotic prescriptions for bacterial infections, and larger vari-
ability in antibiotic prescriptions for viral infections and unknown bacterial/viral infections. In
general, EDs with higher antibiotic prescription rates in viral infections also had higher antibi-
otic prescription rates in unknown bacterial/viral infections. This indicates that overprescrib-
ing in viral infections is linked to higher prescriptions in unknown bacterial/viral infections.
Diagnostic uncertainty in patients with an unclear cause of infection could be reduced by
improved targeted antibiotic prescription from new diagnostic signatures of bacterial and viral
infection.
We evaluated appropriateness in indication, duration, and guideline concordance. Ideally,
EDs should target 100% appropriateness in these 3 aspects of antibiotic prescribing. In our
study, we did not observe a clear association between inappropriately indicated prescriptions
and prescriptions of inappropriate duration. This indicates that guideline implementations
should focus on these different aspects of appropriate antibiotic prescribing to ensure prescrip-
tions of appropriate indication, duration, and antibiotic selection. Furthermore, quality
improvement initiatives should be emphasised in EDs with higher proportions of inappropri-
ate prescriptions. In addition, future antimicrobial stewardship interventions across Europe
should focus on reducing broad-spectrum treatment and antibiotic use in viral infections.
To conclude, we found substantial variation in antibiotic prescriptions and especially
broad-spectrum antibiotic prescriptions in European EDs after adjustment for patient charac-
teristics, disease severity, diagnostics, and focus and cause of infection. The proportion of anti-
biotic prescriptions in bacterial infections was comparable between EDs, but diversity was
especially large in antibiotic prescriptions for viral infections and unknown viral/bacterial
infections. This variation indicates overprescription of antibiotics in these groups of patients.
Furthermore, indications of prescriptions were inappropriate or inconclusive in one-third of
prescriptions, and this proportion varied between EDs. In respiratory and urinary infections,
guideline concordance of prescriptions varied widely across EDs. Until better diagnostics are
available to accurately differentiate between bacterial and viral aetiologies, we strongly urge
the implementation of antimicrobial stewardship guidelines to reduce antibiotic prescription
in febrile children across Europe.
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